Multidisciplinary Approach to Fatigue
Recruiting · NCT05502224 · Interventional (participants receive a specific treatment)
View the official record on ClinicalTrials.gov →Interventions studied
Ergospirometry
What this trial is about
Prospective longitudinal, single-center, non-randomized study for the implementation of an integrated multidisciplinary fatigue follow-up for young patients with breast cancer or germ cell tumour
Who can take part
Age range
18 Years to 39 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Age between 18 and 39 years at the time of signing the informed consent
- Patient who speaks and understands French
- Signed study informed consent form obtained prior to any study related procedures
- At minimum, a moderate (\>3) fatigue level according to the Standard Rating Scale (NRS) 1 month after completion of acute treatment; as measured at the Survivorship of the standard program
- Patient with either: curative breast cancer (AJCC stage I-II-III) or a germ cell tumor
Exclusion criteria
- Refusal to participate in the study
- Patient having chosen to participate in another psychosocial intervention study for the duration of the study.
- Patients with AJCC stage IV breast cancer
Where it is running
1 location listed.
- Institut Jules Bordet - Brussels, Belgium